122
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Micro-Rna335-5P Targeted Inhibition of SKLOTHO and Promoted Oxidative Stress–Mediated Aging of Endothelial Cells

, , , , , , & show all
Pages 457-466 | Received 18 Dec 2018, Accepted 31 Jan 2019, Published online: 20 Feb 2019

References

  • Mcaloon CJ , BoylanLM, HamborgTet al. The changing face of cardiovascular disease 2000–2012: an analysis of the World Health Organisation global health estimates data. Int. J. Cardiol.224, 256–264 (2016).
  • Benjamin EJ , BlahaMJ, ChiuveSEet al. Heart Disease and Stroke Statistics – 2017 Update: a report from the American Heart Association. Circulation135 (10), e146–e603 (2017).
  • Huang Q , QinL, DaiSet al. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol.33 (4), 795–804 (2013).
  • Messner B , BernhardD. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler. Thromb. Vasc. Biol.34 (3), 509–515 (2014).
  • Theodorou K , BoonRA. Endothelial cell metabolism in atherosclerosis. Front. Cell Dev. Biol.6, 82 (2018).
  • Wu B , MottolaG, SchallerM, UpchurchGRJr, ConteMS. Resolution of vascular injury: specialized lipid mediators and their evolving therapeutic implications. Mol. Aspects Med.58, 72–82 (2017).
  • Brennan E , WangB, McClellandAet al. Protective effect of let-7 miRNA family in regulating inflammation in diabetes-associated atherosclerosis. Diabetes66 (8), 2266–2277 (2017).
  • Funamoto K , YoshinoD, MatsubaraKet al. Endothelial monolayer permeability under controlled oxygen tension. Integr. Biol.9 (6), 529–538 (2017).
  • Kuro-O M , MatsumuraY, AizawaHet al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature390 (6655), 45–51 (1997).
  • Kurosu H , YamamotoM, ClarkJDet al. Suppression of aging in mice by the hormone Klotho. Science309 (5742), 1829–1833 (2005).
  • Imura A , IwanoA, TohyamaOet al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett.565 (1–3), 143–147 (2004).
  • Matsumura Y , AizawaH, Shiraki-IidaT, NagaiR, Kuro-OM, NabeshimaY. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun.242 (3), 626–630 (1998).
  • Liu Z , ZhangH, DingSet al. betaKlotho inhibits androgen/androgen receptor associated epithelial mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling. Oncol. Rep.40 (1), 217–225 (2018).
  • Wang Y , SunZ. Antiaging gene Klotho regulates endothelin-1 levels and endothelin receptor subtype B expression in kidneys of spontaneously hypertensive rats. J. Hypertens.32 (8), 1629–1636 ; discussion 1636 (2014).
  • Carracedo J , BuendiaP, MerinoAet al. Klotho modulates the stress response in human senescent endothelial cells. Mech. Ageing Dev.133 (11–12), 647–654 (2012).
  • Ikushima M , RakugiH, IshikawaKet al. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem. Biophys. Res. Commun.339 (3), 827–832 (2006).
  • Yang K , NieL, HuangYet al. Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. Toxicol. Lett.215 (2), 77–83 (2012).
  • Richter B , HallerJ, HaffnerD, Leifheit-NestlerM. Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Pflugers Arch.468 (9), 1621–1635 (2016).
  • Harris TA , YamakuchiM, FerlitoM, MendellJT, LowensteinCJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl Acad. Sci. USA105 (5), 1516–1521 (2008).
  • Parmar KM , LarmanHB, DaiGHet al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest.116 (1), 49–58 (2006).
  • Zhou J , WangKC, WuWet al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc. Natl Acad. Sci. USA108 (25), 10355–10360 (2011).
  • Taganov KD , BoldinMP, ChangKJ, BaltimoreD. NF-kappa B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA103 (33), 12481–12486 (2006).
  • Cheng HS , SivachandranN, LauAet al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol. Med.5 (7), 1017–1034 (2013).
  • Rau CS , YangJCS, ChenYCet al. Lipopolysaccharide-induced microRNA-146a targets CARD10 and regulates angiogenesis in human umbilical vein endothelial cells. Toxicol. Sci.140 (2), 315–326 (2014).
  • Asgeirsdottir SA , Van SolingenC, KurniatiNFet al. MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation. Am. J. Physiol-Renal.302 (12), F1630–F1639 (2012).
  • Wu W , XiaoH, Laguna-FernandezAet al. Flow-dependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a. Circulation124 (5), 633–641 (2011).
  • Wang Y , LeeCGL. MicroRNA and cancer: focus on apoptosis. J. Cell Mol. Med.13 (1), 12–23 (2009).
  • Liu D , ZhangXL, YanCHet al. MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2. Thromb. Res.135 (1), 146–154 (2015).
  • Tome M , SepulvedaJC, DelgadoMet al. miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity. Stem Cells32 (8), 2229–2244 (2014).
  • Raihan O , BrishtiA, MollaMRet al. The age-dependent elevation of miR-335-3p leads to reduced cholesterol and impaired memory in brain. Neuroscience390, 160–173 (2018).
  • Bai XY , MaY, DingR, FuB, ShiS, ChenXM. miR-335 and miR-34a promote renal senescence by suppressing mitochondrial antioxidative enzymes. J. Am. Soc. Nephrol.22 (7), 1252–1261 (2011).
  • Sun Z , ZhangZ, LiuZ, QiuB, LiuK, DongG. MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2. Med. Oncol.31 (6), 982 (2014).
  • Lynch J , MeehanMH, CreanJ, CopelandJ, StallingsRL, BrayIM. Metastasis suppressor microRNA-335 targets the formin family of actin nucleators. PLoS ONE8 (11), e78428 (2013).
  • Jiang F , LiJ, WuGet al. Upregulation of microRNA335 and microRNA584 contributes to the pathogenesis of severe preeclampsia through downregulation of endothelial nitric oxide synthase. Mol. Med. Rep.12 (4), 5383–5390 (2015).
  • Zhang JB , ZhuXN, CuiJ, ChenP, WangSM, WangJS. Differential expressions of microRNA between young and senescent endothelial cells. Zhonghua Yi Xue Za Zhi92 (31), 2205–2209 (2012).
  • Sui XQ , XuZM, XieMB, PeiDA. Resveratrol inhibits hydrogen peroxide-induced apoptosis in endothelial cells via the activation of PI3K/Akt by miR-126. J. Atheroscler. Thromb.21 (2), 108–118 (2014).
  • Harries LW . MicroRNAs as mediators of the ageing process. Genes (Basel)5 (3), 656–670 (2014).
  • Wadley AJ , Van ZantenJJCSV, AldredS. The interactions of oxidative stress and inflammation with vascular dysfunction in ageing: the vascular health triad. Age35 (3), 705–718 (2013).
  • Cevenini E , CarusoC, CandoreGet al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des.16 (6), 609–618 (2010).
  • Forstermann U , XiaN, LiH. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ. Res.120 (4), 713–735 (2017).
  • Tousoulis D , SimopoulouC, PapageorgiouNet al. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches. Pharmacol. Ther.144 (3), 253–267 (2014).
  • Mudau M , GenisA, LochnerA, StrijdomH. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc. J. Afr.23 (4), 222–231 (2012).
  • Sun S , ChengB, SunPG, WuXH, WuQQ, HeP. RTEF-1 protects against oxidative damage induced by H2O2 in human umbilical vein endothelial cells through Klotho activation. Exp. Biol. Med. (Maywood)240 (12), 1606–1613 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.